Press
For partnership inquiries, research collaboration, or product information, please contact us at: contact@chelseymoss.com
Esmé SX and MindMics Announce Strategic Partnership to Advance Biometric Intelligence in Women’s Sexual Wellness
April 2025
At the forefront of female-founded innovation, sexual wellness technology company Esmé SX and advanced digital health company MindMics have announced a strategic partnership to expand access to personalized, biometric-powered insights for women’s health and pleasure.
Esmé SX is redefining the $115B sexual wellness industry with a first-of-its-kind, biometric-responsive platform combining thermoacoustic stimulation, adaptive feedback, and real-time biometric intelligence. The company’s debut device delivers deep-wave clitoral stimulation designed to promote nerve cell activation, synaptic plasticity, and enhanced neurochemistry for expanded and multi-orgasmic experiences.
“In general, it takes women 20–30 minutes to reach climax—partly due to blood flow from the brain to the pelvic region. A dysregulated nervous system braces against receptivity. Our partnership with MindMics gives women real-time biofeedback to identify when they’re in a state of Rest & Digest —unlocking new pathways to pleasure through breath, sound, and embodied awareness.” — Chelsey Moss, CEO, Esmé SX
MindMics’ breakthrough in-ear infrasonic technology captures real-time biometric data through a new science known as infrasonic hemodynography—enabling sub-heart rate fidelity with clinical-grade precision.
“We are thrilled to partner with Esmé SX, as they bring a fresh, holistic approach to sexual wellness. We believe that our real-time biofeedback technology can offer a results-oriented method to help women discover the most effective strategies for their well-being. This collaboration aligns perfectly with our goal to empower individuals by providing personalized and actionable health insights.”
— Dr. Anna Barnacka, CEO, MindMics
Together, Esmé SX and MindMics deliver a neurosomatic approach to sexual wellness—merging precision biometric tracking with adaptive clitoral stimulation to help women optimize their orgasmic response, regulate their nervous system, and unlock deeper insights into their health.
The Esmé SX White Paper Is Now Live — The Future of Biometric - Responsive Intimacy
March 2025
Published by Esmé SX
Lead Author: Chelsey Moss, Founder & CEO
Advancing Women’s Health & Wellness Through Innovation: Driving Change with Science-Backed Solutions
Executive Summary
Esmé SX is a mission-driven technology company transforming women’s health and wellness through science-backed innovation. By combining cutting-edge research with pioneering product development, Esmé SX is closing the healthcare gap and delivering targeted solutions for women’s unique needs. Our commitment to advancing sexual wellness and overall well-being empowers women to live healthier, happier lives — redefining the future of women’s health.
The Women’s Health Gap: A Critical Need for Innovation Women’s health has historically been under-researched, underfunded, and underserved. Despite accounting for over 50% of the global population, women face significant gaps in diagnosis, treatment, and access to personalized care. Additionally, the global femtech market is projected to grow significantly, with increasing consumer demand for personalized, science-backed solutions addressing hormonal balance, sexual wellness, and mental health. Read Full Report
Dr. Zarychta’s expertise in biomedical engineering and her proven ability to assess the potential of novel technologies make her an invaluable asset to Esmé SX. Her strong technical foundation, combined with her business acumen and global leadership experience across Europe, Asia-Pacific, and the Middle East, enables her to effectively advise on navigating complex challenges and driving impactful results in the healthcare industry.
Welcoming Dr. KaT Zarychta as Chief Medical Advisor — Advancing Scientific Integrity in Women's Sexual Wellness
January 2025
Esmé SX Welcomes Dr. KaT Zarychta as Chief Medical Advisor
We at Esmé SX are elated to have Dr. KaT Zarychta join our team as Chief Medical Advisor; ensuring the scientific rigor of Esmé SX's revolutionary resonant frequency technology and guiding our mission to bridge the gap between sexual wellness and overall health — empowering women to achieve optimal well-being.
A warm welcome:
Dr. Katarzyna Zarychta, PhD, MSc Eng, is the Chief Medical Advisor at Esmé SX, leveraging over 20 years of experience in the healthcare industry. Driven by a passion for innovation and a deep understanding of holistic health, Dr. Zarychta holds a PhD in Laser Physics from Sorbonne University (Paris), Master's degrees in Physics and Biomedical Engineering, and has completed executive programs at Harvard Business School and Harvard Medical School. This robust academic foundation, coupled with her experience evaluating groundbreaking medical devices and digital health solutions for the European Commission, demonstrates her unwavering commitment to advancing innovation and well-being.